Comprehensive analysis of genetic alterations in NSCLC has identified key signaling pathways and genes, such as EGFR, TP53, KRAS, PIK3CA, STK11, BRAF, ERBB2, MET, and PARK2 [34–37]. Here, ERBB2 is linked to non-small cell lung carcinoma.